177 related articles for article (PubMed ID: 26945536)
1. Erythrokeratodermia variabilis et progressiva.
Ishida-Yamamoto A
J Dermatol; 2016 Mar; 43(3):280-5. PubMed ID: 26945536
[TBL] [Abstract][Full Text] [Related]
2. Erythrokeratodermia variabilis et progressiva due to a novel mutation in GJB4.
Zhang X; Xu P; Lu J; Ding Y; Gu J; Shi Y
Exp Dermatol; 2022 Apr; 31(4):594-599. PubMed ID: 34717022
[TBL] [Abstract][Full Text] [Related]
3. Two de novo GJA1 mutation in two sporadic patients with erythrokeratodermia variabilis et progressiva.
Li C; Liang J; Chen P; Zeng K; Xue R; Tian X; Liang L; Wang Q; Shi M; Zhang X
Mol Genet Genomic Med; 2019 Jun; 7(6):e670. PubMed ID: 30924322
[TBL] [Abstract][Full Text] [Related]
4. Dominant De Novo Mutations in GJA1 Cause Erythrokeratodermia Variabilis et Progressiva, without Features of Oculodentodigital Dysplasia.
Boyden LM; Craiglow BG; Zhou J; Hu R; Loring EC; Morel KD; Lauren CT; Lifton RP; Bilguvar K; Paller AS; Choate KA
J Invest Dermatol; 2015 Jun; 135(6):1540-1547. PubMed ID: 25398053
[TBL] [Abstract][Full Text] [Related]
5. Erythrokeratodermia variabilis et progressiva allelic to oculo-dento-digital dysplasia.
Duchatelet S; Hovnanian A
J Invest Dermatol; 2015 Jun; 135(6):1475-1478. PubMed ID: 25964267
[TBL] [Abstract][Full Text] [Related]
6. Interrogation of Carboxy-Terminus Localized
Lucaciu SA; Shao Q; Figliuzzi R; Barr K; Bai D; Laird DW
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008913
[TBL] [Abstract][Full Text] [Related]
7. Erythrokeratodermia variabilis: report of two cases and a novel missense variant in GJB4 encoding connexin 30.3.
Kokotas H; Papagiannaki K; Grigoriadou M; Petersen MB; Katsarou A
Eur J Dermatol; 2012; 22(2):182-6. PubMed ID: 22266302
[TBL] [Abstract][Full Text] [Related]
8. Genetic heterogeneity in erythrokeratodermia variabilis: novel mutations in the connexin gene GJB4 (Cx30.3) and genotype-phenotype correlations.
Richard G; Brown N; Rouan F; Van der Schroeff JG; Bijlsma E; Eichenfield LF; Sybert VP; Greer KE; Hogan P; Campanelli C; Compton JG; Bale SJ; DiGiovanna JJ; Uitto J
J Invest Dermatol; 2003 Apr; 120(4):601-9. PubMed ID: 12648223
[TBL] [Abstract][Full Text] [Related]
9. Erythrokeratoderma variabilis caused by a recessive mutation in GJB3.
Fuchs-Telem D; Pessach Y; Mevorah B; Shirazi I; Sarig O; Sprecher E
Clin Exp Dermatol; 2011 Jun; 36(4):406-11. PubMed ID: 21564177
[TBL] [Abstract][Full Text] [Related]
10. Clinical variability of the GJB4:c.35G > A gene variant: a study of a large Brazilian erythrokeratodermia pedigree.
de Oliveira RTG; Christofolini DM; Criado PR; Lacaz Martins E; Kelsell D; Machado Filho CDS
Int J Dermatol; 2020 Jun; 59(6):722-725. PubMed ID: 32311086
[TBL] [Abstract][Full Text] [Related]
11. Novel and recurrent connexin 30.3 and connexin 31 mutations associated with erythrokeratoderma variabilis.
Scott CA; O'Toole EA; Mohungoo MJ; Messenger A; Kelsell DP
Clin Exp Dermatol; 2011 Jan; 36(1):88-90. PubMed ID: 21188847
[TBL] [Abstract][Full Text] [Related]
12. Novel and recurrent mutations in GJB3 and GJB4 cause erythrokeratodermia variabilis et progressiva.
Dai S; Wang H; Lin Z
Indian J Dermatol Venereol Leprol; 2020; 86(1):87-90. PubMed ID: 31793497
[No Abstract] [Full Text] [Related]
13. Erythrokeratodermia variabilis et progressiva with a rare GJB3 mutation.
Imura K; Ikeya S; Ogata T; Tokura Y
J Dermatol; 2020 Apr; 47(4):e111-e113. PubMed ID: 31912549
[No Abstract] [Full Text] [Related]
14. Erythrokeratodermia Variabilis-like Phenotype in Patients Carrying
Hotz A; Fölster-Holst R; Oji V; Bourrat E; Frank J; Marrakchi S; Ennouri M; Wankner L; Komlosi K; Alter S; Fischer J
Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540347
[TBL] [Abstract][Full Text] [Related]
15. Novel mutation in GJB4 gene (connexin 30.3) in a family with erythrokeratodermia variabilis.
Sbidian E; Bousseloua N; Jonard L; Leclerc-Mercier S; Bodemer C; Hadj-Rabia S
Acta Derm Venereol; 2013 Mar; 93(2):193-5. PubMed ID: 23037955
[No Abstract] [Full Text] [Related]
16. A sporadic elder case of erythrokeratodermia variabilis with a single base-pair transversion in GJB3 gene successfully treated with systemic vitamin A derivative.
Otaguchi R; Kawakami T; Matsuoka M; Kimura S; Soma Y; Matsuda M; Hamada T; Hashimoto T
J Dermatol; 2014 Nov; 41(11):1016-8. PubMed ID: 25297803
[No Abstract] [Full Text] [Related]
17. Connexins: a connection with the skin.
Richard G
Exp Dermatol; 2000 Apr; 9(2):77-96. PubMed ID: 10772382
[TBL] [Abstract][Full Text] [Related]
18. A rare missense mutation in GJB3 (Cx31G45E) is associated with a unique cellular phenotype resulting in necrotic cell death.
Easton JA; Albuloushi AK; Kamps MAF; Brouns GHMR; Broers JLV; Coull BJ; Oji V; van Geel M; van Steensel MAM; Martin PE
Exp Dermatol; 2019 Oct; 28(10):1106-1113. PubMed ID: 29570224
[TBL] [Abstract][Full Text] [Related]
19. An unusual missense mutation in the GJB3 gene resulting in severe erythrokeratodermia variabilis.
Glatz M; van Steensel MA; van Geel M; Steijlen PM; Wolf P
Acta Derm Venereol; 2011 Oct; 91(6):714-5. PubMed ID: 21879244
[No Abstract] [Full Text] [Related]
20. Mutation analysis of GJB3 and GJB4 in Chinese patients with erythrokeratodermia variabilis.
Liu H; Liu H; Fu XA; Yu YX; Zhou GZ; Lu XM; Tian HQ; Yu CP; Shi ZX; Yu ML; Zhang FR
J Dermatol; 2012 Apr; 39(4):400-1. PubMed ID: 21950330
[No Abstract] [Full Text] [Related]
[Next] [New Search]
